NCT02245932View on ClinicalTrials.gov

Resveratrol In Chronic Obstructive Pulmonary Disease (COPD) Patients (CARMENS-trial)

NACompletedINTERVENTIONAL
Enrollment

23

Participants

Timeline

Start Date

January 31, 2015

Primary Completion Date

November 30, 2017

Study Completion Date

November 30, 2017

Conditions
Pulmonary Disease, Chronic Obstructive
Interventions
DIETARY_SUPPLEMENT

Resveratrol

4 weeks of 150 mg resveratrol (2 times 75mg/day)

DIETARY_SUPPLEMENT

Placebo

4 weeks of placebo supplementation (two doses per day)

Trial Locations (1)

Unknown

Maastricht University Medical Center, Maastricht

All Listed Sponsors
collaborator

The Netherlands Asthma Foundation

OTHER

collaborator

DSM Nutritional Products, Inc.

INDUSTRY

lead

Maastricht University Medical Center

OTHER

NCT02245932 - Resveratrol In Chronic Obstructive Pulmonary Disease (COPD) Patients (CARMENS-trial) | Biotech Hunter | Biotech Hunter